New Pipeline Reveals RNA Fusions Formed During Inflammation, Opens New Frontier in Biology

Oct 20, 2026
Illustration of RNA fusionAI-generated from publicly available materials.

Recent research has unveiled a groundbreaking mechanism by which immune cells generate novel messenger RNAs during inflammatory responses, potentially redefining our understanding of gene functionality.

Scientists have discovered that during inflammation, immune cells can create chimeric mRNAs by fusing segments from disparate genes, a process previously thought to result mainly from DNA damage. This study, led by researchers at Harvard Medical School, demonstrates that these fused RNAs play a significant role in the immune system's ability to combat infections, challenging the traditional view that such occurrences are merely accidents resulting from genomic instability.

Dr. Ruaidhrí Jackson and his team revealed that inflammation causes structural changes in DNA, bringing distant genes into proximity, which facilitates the fusion of RNA transcripts. This suggests that the mammalian proteome may be more extensive than previously recognized, as new hybrid proteins could contribute to immune functions. The research indicates that these chimeric mRNAs are not just artifacts but serve essential roles in immune defense, particularly in how cells respond to pathogens.

The innovative multi-technology pipeline developed by the researchers was crucial for identifying and validating these functional chimeric mRNAs. This methodology combines various sequencing techniques and CRISPR technology to eliminate false positives, thus providing a reliable framework for future studies. The implications of this work extend beyond immunology, hinting at a previously unrecognized layer of gene regulation that could influence research in cancer, development, and other diseases.

In summary, the findings present a paradigm shift in our understanding of gene interactions and their implications for immune response, suggesting that the biological landscape is richer and more complex than previously thought. This could open new avenues for therapeutic interventions targeting these chimeric RNAs in various diseases.

Read the original article: Bio-IT World